John Kirby & KJP Say Biden is Going to Hold a ‘Big Boy’ Press Conference This Week
John Kirby and Karine Jean-Pierre have announced that Joe Biden will be holding a ‘big boy’ press conference this week. Yes, the two White House officials really did say that when referring to an upcoming […]
The post John Kirby & KJP Say Biden is Going to Hold a ‘Big Boy’ Press Conference This Week appeared first on The People’s Voice.
Watch Live: Biden Hosts D.C. NATO Summit As His Campaign Crumbles
“The American Journal” is live every weekday from 8-11 am CST.
Follow The American Journal on Telegram:
RSV Vaccine Now Killing Babies — VAERS Reports
At least two infants died after they were mistakingly given Pfizer’s respiratory syncytial virus (RSV) vaccine along with Nirsevimab, a monoclonal antibody injection approved for infants that’s meant to prevent RSV.
A 29-day-old premature girl died after receiving an RSV shot meant for the elderly, according to the Vaccine Adverse Event Reporting System (VAERS).
“According to the mother, the patient departed the clinic at 1 pm after the vaccine was administered. Subsequently, the patient took a nap and at approximately 8 pm, the father observed that the patient was not breathing. The parents attempted CPR but it was unsuccessful,” the VAERS report said. “Shortly thereafter, the parents called both ambulance and police assistance. Upon the paramedics” arrival, the patient had already deceased; The causes of death are unknown, An autopsy is presently in the process of being investigated. The mother has not yet reported the exact cause of death, information was given via a telephone call.”
A 27-day-old boy also received the RSV shot, which resulted in a similar fate.
“Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there; Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there; This is a spontaneous report received from a Consumer or other non HCP. A 27-day-old male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient”s relevant medical history and concomitant medications were not reported,” the VARES report said. “The following information was reported: DEATH (death, medically significant), outcome “fatal”, PRODUCT USE ISSUE (non-serious), outcome “unknown” and all described as “Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there”. The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v will be requested and submitted if and when received.; Reported Cause(s) of Death: Her son was only 27 days old and received the vaccine at doctor”s office and he passed away right there.”
Notably, the monoclonal antibody Beyfortus (also known as Nirsevimab) which is produced by Sanofi and AstraZeneca also has a checkered safety record.
According to a published CDC paper from 2021, 25 babies up to one year of age die from RSV yearly in the US.
— Children’s Health Defense (@ChildrensHD) August 4, 2023
12 innocent babies died DURING the nirsevimab trial; the so-called “powerful tool to protect children against RSV,” according to @CDCDirector
This information,… https://t.co/gBI51uozgQ
The monoclonal antibody is intended to be injected into infants born during the ‘RSV season’ and marketed as a ‘powerful tool’.
Interestingly, even when the RSV vaccine is given to the target demographic, seniors, a medical study said the RSV-vaccinated experienced allergic reactions as well as serious heart and nervous system disorders.
“At the data-cutoff date, 2.3% of the vaccine recipients and 2.3% of the placebo recipients had reported serious adverse events, and three of these events were considered by the investigators to be related to the trial intervention. The first serious adverse event was a delayed allergic reaction 7 hours after injection of RSVpreF vaccine, with recovery on the same day. The second serious adverse event was a combination of diplopia, paresthesia of palms and soles, and oculomotor and abducens nerve paralysis 8 days after injection in a participant in the vaccine group who had a medical history of diabetes mellitus; this event was retrospectively diagnosed as being consistent with the Miller–Fisher syndrome (a subset of the Guillain–Barré syndrome characterized by ophthalmoplegia, ataxia, and areflexia). A spinal tap and nerve-conduction studies were not performed, and the participant recovered,” the study said in the ‘Safety’ section. “The last serious adverse event, also in a participant in the vaccine group, was myocardial infarction that developed 6 days after injection. This participant then underwent angioplasty and later received a diagnosis of acute inflammatory demyelinating polyradiculoneuropathy, consistent with Guillain–Barré syndrome, that began 7 days after injection. The participant continued to recover and regained most motor function. No trial intervention–related deaths or adverse events leading to withdrawal from the trial were reported.”
While the RSV vaccine the infants received was a classic vaccine, Moderna recently had their mRNA-based RSV vaccine approved for human use, set to be injected into patients later this year.
BREAKING: Biden Pledges To Never Leave, Throwing Deep State Into Panic
Biden Plans To Win A Second Term, Says “I’m Not Going Anywhere”
Joe Biden has vowed to continue his reelection campaign telling MSNBC that he is “not going anywhere”. Despite the growing and widespread concerns about his mental health, Biden even claimed he is “the best candidate […]
The post Biden Plans To Win A Second Term, Says “I’m Not Going Anywhere” appeared first on The People’s Voice.
Ukraine and Poland Sign Security Agreement, Commit to Forming Ukrainian Legion in Poland
Poland and Ukraine have cemented their commitment to each other’s security by signing a new agreement on mutual assistance. The signing ceremony took place in Warsaw, where Ukrainian President Volodymyr Zelensky met with Polish Prime Minister Donald Tusk.
During a joint press conference, the leaders detailed their discussions and began the meeting with a moment of silence for the victims of Monday’s Russian attack on Kyiv which killed dozens including children in a cancer hospital.
“The words are insufficient to condemn the aggressor,” Tusk remarked as he discussed the brutalities of the conflict. He stressed the importance of the newly signed document, the Security Cooperation Agreement between Poland and Ukraine, emphasizing that it was about real commitments, not empty promises.
????? pic.twitter.com/WmV6tNK1S1
— Chancellery of the Prime Minister of Poland (@PremierRP_en) July 8, 2024
“We will fulfill the provisions of this agreement with our allies. If this war ends badly, it would be a disaster not only for Ukraine but also for Poland, Europe, and the entire Western world,” Tusk said.
The Polish leader reassured that his country would do everything possible to assist Ukraine. In response, President Zelensky highlighted the “inevitable rebuilding of what Russian terrorists have destroyed” and promised accountability for those, including Putin, responsible for civilian attacks.
Zelensky thanked Poland for 44 military aid packages and described the Warsaw agreement as “very ambitious.”
“It will help us protect the lives of our citizens,” he added, noting that more such packages are expected this year.
The leaders agreed to establish and train a Ukrainian legion on Polish soil, a new volunteer force. Tusk also touched upon Ukraine’s path to NATO membership, acknowledging it was longer than Poland would prefer, but assured of ongoing persuasion of NATO allies to expedite Ukraine’s integration into the EU.
“We will also ensure that nothing about Ukraine is decided without Ukraine,” Tusk concluded, affirming continued Polish support for Ukraine.
BREAKING: Biden Pledges To Never Leave, Throwing Deep State Into Panic
Creepy Supercomputers Run by Lab-Grown Human Brains Unveiled by WEF-Funded Scientists
If you thought some aspects of AI’s capabilities were creepy, brace yourself for FinalSpark’s new “Neuroplatform” that is run by lab-grown human brains.
The Swiss tech startup is selling access to biocomputers that use a series of small lab-grown human brains for power, which means they only need “a fraction of the energy required to power a traditional computer.”
Not surprisingly, the scientists’ work is being funded by the globalists at the World Economic Forum.
The new bioprocessing Neuroplatform is powered by these tiny brains, with as many as 16 of them working together to power it. It has already been adopted by nine institutions and is being lauded for its ability to save energy. The company boasts that 16 of these lab-created brains use a million times less power than the traditional silicon chips that power such systems.
Neuroplatform combines hardware, software and biology, and it is considered “wetware” because it involves a biological component. It relies on a setup of Multi-Electrode Arrays (MEAs) that are used to house the 3D masses of brain tissue, with each MEA holding four lab-grown brains interfaced with eight electrodes that both stimulate them and record their data processing.
Enslaved little brains subjected to punishment before being worked to death
However, the fact that these little human brains have been essentially enslaved to run the platform is being largely glossed over. It can be a difficult concept to grasp because it’s so far outside the realm of traditional computing, but the fact remains that thousands of living neurons make up these brains and are being kept alive using a “microfluidics system that supplies water and nutrients for the cells.”
They are calling these brain cells “organoids,” and they are trained to perform the desired tasks with a reward and punishment system. When they act as expected, they are given dopamine as a reward, which is the human neurotransmitter behind pleasure and addiction, while the organoids are exposed to more chaotic stimuli, like irregular electrical activity, when those training them want to punish them – essentially torturing these little brains into obedience.
FinalSpark wants their scary technology to serve as the main energy source for AI given the huge energy inputs required to train and run the technology.
Interesting Engineering notes: “According to Final Spark’s estimates, training the popular large language model GPT-3 that powered ChatGPT in its initial days alone consumed 10 GWh of energy. This is a whopping 6,000 times more energy than an average European city consumes in an entire year. Replacing silicon chips with bioprocessors could lead to drastic energy savings.”
Another complication here is the fact these mini brains are constantly dying and need to be replaced. The scientists have been improving their lifespans; while they used to die within hours, they can now survive for 100 days before being essentially worked to death.
Although the platform’s creators maintain that the mini brains are not sentient, this type of endeavor is worrying on so many different levels, and it’s easy to see where all this could be headed.
In fact, FinalSpark openly shares their unsettling vision for overtaking nature on their website, declaring: “We’re growing neurons in cell cultures and making great progress in their use as computing power. Creating large networks is challenging and yet, our bio lab is actively working towards replicating and surpassing nature’s success with limitless potential for enhancing life on earth. The possibilities are very exciting.”
Of course, it’s hard to imagine who could be more excited about these “possibilities” than the World Economic Forum.
BREAKING: Biden Pledges To Never Leave, Throwing Deep State Into Panic